Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1099 · · 11 pages · English
Summary by 6ix AI
It includes information on the movements in authorized and registered share capital, as well as issued shares and public float sufficiency confirmation. The total authorized share capital at the end of the month is reported, along with confirmations regarding public float compliance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sinopharm Group Co., Ltd. on 6ix
Earlier from Sinopharm
- Interim Report 2026
- Announcement (1) poll results of the extraordinary general meeting held on Tuesday, 15 September 2026; and (2) election of chairman and vice chairman of the board, and chairmen and members of the special committees of the board
- Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Later from Sinopharm
- Notice of board meeting
- An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
- Announcement principal unaudited accounting data and financial indicators of sinopharm (cncm ltd) for the third quarter of 2026
- Announcement preliminary financial data of sinopharm accord for the nine months ended 30 September 2026
- Announcement principal unaudited financial data of cnmdc for the nine months ended 30 September 2026
Follow Sinopharm into a list and get an email when it puts out news.
Follow Sinopharm